Letrozole Tablets 2.5 MG – Targeted Therapy to manage Breast cancer
STEFALET 2.5 Tablets – Letrozole tablet 2.5 mg is a non-steroidal type II aromatase inhibitor medication and primarily helps to treat breast cancer and Hormone receptor-positive breast cancer (Menopause). It works by inhibiting the conversion of androgens to estrogen reduces the levels of estrogen helps to manage estrogen-dependent tumors and cancer cells.
Recommended by specialists:
✅Oncologist: To manage breast cancer
✅Gynecologist: To treat breast cancer and PCOD in menopause.
Key benefits of Letrozole Tablets 2.5 MG – STEFALET 2.5 Tablets:
✅Non-steroidal medication: As a non-steroidal aromatase inhibitor it minimizes side effects as compared to steroidal medications.
✅Effective Hormonal Therapy: Particularly beneficial for hormone receptor-positive breast cancer.
✅Post-Surgical Support: It is used after surgery to manage the risk of cancer recurrence.
✅Improved Conditions: Enhances survival rates in postmenopausal women with breast cancer.
Indications:
✅Breast cancer
✅Hormone receptor-positive breast cancer (Menopause)
✅Ovulation in PCOD